close
close
Revolution heralded as “Outperform” – Oppenheimer rating from Investing.com

Revolution heralded as “Outperform” – Oppenheimer rating from Investing.com

Oppenheimer got an “Outperform” rating and a $55.00 valuation for Revolution (NASDAQ: RVMD). The Investmentbank received many updates from the latest triple meetings on October 23-25, einschließlich einer Investorenveranstaltung on October 25. The focus is on the Optimismus für dos Pharmaunternehmen, das sich darauf vorbereitet, Aktualisierungen zu seinen Medikamentenkandidaten zu präsentieren. Revolution wird voraussichtlich mehrere…

Read More
Osteoporosis: Innovative osteoporosis medicines that transform the lives of postmenopausal women | Pune News

Osteoporosis: Innovative osteoporosis medicines that transform the lives of postmenopausal women | Pune News

Pune: Meera, a 52-year-old woman, began experiencing debilitating back pain and joint discomfort soon after menopause. Although she initially attributed her symptoms to aging and the stress of daily life, she soon realized that her condition was much more serious.After a thorough examination and basic x-ray, Meera was diagnosed with spinal fracture at the endplate…

Read More
Back To Top